Company: EDSA
Filing Date: 2025-02-13
Form Type: 8-K
Source: 0001171843-25-000796
Chunk: 3

Company: Edesa Biotech, Inc.
Filing Date: 2025-02-13
Form: 8-K
Item: Item 3.02
Chunk 3
---
Item 3.02 Unregistered Sales of Equity Securities.

The information contained above in Item 1.01 is hereby incorporated by
reference into this Item 3.02. The Preferred Shares, Conversion Shares and Shares (collectively, the “ Securities”)
have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), and were offered pursuant
to the exemption provided in Section 4(a)(2) under the Securities Act and Rule 506(b) promulgated thereunder. The Securities were offered
in a private placement in Canada to “accredited investors” within the meaning of the CanadianNational Instrument 45-106
- Prospectus Exemptions. The Securities issued are subject to applicable Canadian hold periods imposed under applicable securities
legislation.

Item 3.03 Material Modiﬁcation to Rights of Security Holders.